Boehringer Ingelheim Symposium
Date: Thursday 29 September 2022
Time: 13:15–14:30 CET
Duration: 75 min
Title: Exploring a New Path Forward in Generalized Pustular Psoriasis
Objectives:
– Describe the clinical features and disease burden of GPP flares for patients– Appreciate that GPP is a distinct clinical entity from plaque psoriasis
– Review the evidence highlighting the central role of IL-36 in GPP
– Discuss the unmet needs in GPP treatment, and present targeted GPP-specific treatments in development
Chair – Peter van de Kerkhof
- Speakers: Mahira El Sayed, Siew-Eng Choon, Johann Gudjonsson
PROGRAM
|
|
13.15–13.20 | Welcome and Introductions Peter van de Kerkhof (The Netherlands)
|
13.20–13-35 | Rough Terrain: Current Challenges with GPP Flares Mahira El Sayed (Egypt)
|
13.35–13.50 | A Fork in the Road: Distinguishing GPP from Plaque Psoriasis Siew-Eng Choon (Malaysia)
|
13.50–14.05 | IL-36: Exploring a Central Pathway in GPP Johann Gudjonsson (United States)
|
14.05–14.20 | Forging a New Path in GPP: From Bench to Bedside Peter van de Kerkhof (The Netherlands)
|
14.20–14.30 | Q&A and Closing Remarks All Above Speakers |